Target intelligence / Profile preview

Idiotype–anti-idiotype antibody network

Molecular classification
Immune system network, Immunoglobulin complex
01

Overview

The idiotype–anti-idiotype antibody network is a complex regulatory system within the adaptive immune system, originally proposed by Niels Jerne (Jerne, 1974, Ann. Immunol.). It posits that the variable regions (idiotypes) of antibodies and B-cell receptors are themselves recognized as antigens by other antibodies (anti-idiotypes), creating a self-regulating web that maintains immune homeostasis and self-tolerance (Shoenfeld, 2004, Cleve. Clin. J. Med.). In healthy individuals, this network helps suppress the expansion of autoreactive B-cell clones and regulates the magnitude of immune responses to foreign antigens (Lemke, 2014, Encycl. Med. Immunol.). Dysregulation of this network is implicated in the development of autoimmune diseases, where the balance between pathogenic autoantibodies and protective anti-idiotypes is lost. Therapeutically, this system is exploited through the use of intravenous immunoglobulin (IVIG), which contains a diverse array of anti-idiotypic antibodies that can neutralize pathogenic autoantibodies (Kazatchkine & Dietrich, 1993, Clin. Exp. Immunol.). Furthermore, idiotype vaccines are used in the treatment of B-cell lymphomas to induce a specific immune response against the unique idiotypes expressed on the surface of malignant B cells. The study of B-cell and autoantibody repertoires within this network provides insights into the mechanisms of immune memory and the transition from health to chronic inflammatory disease.

Other names
Idiotypic networkJerne's network theoryAntibody-mediated immune regulationB-cell repertoireAnti-idiotypic regulation
02

Mechanism of action

Modulation of immune homeostasis through the binding of anti-idiotypic antibodies to the variable regions (idiotypes) of pathogenic autoantibodies or B-cell receptors, leading to neutralization of the antibodies or suppression of the corresponding B-cell clones (Kazatchkine & Dietrich, 1993, Clin. Exp. Immunol.).

03

Biological functions

Immune regulationHomeostasisSelf-toleranceB-cell signalingAntibody production regulation
04

Disease associations

Autoimmune diseaseB-cell lymphomaSystemic lupus erythematosusMyasthenia gravisChronic inflammation
05

Safety considerations

Immune complex formationSystemic inflammationPotential for inducing autoimmunityOff-target immune suppressionCytokine release syndrome
06

Interacting drugs

Intravenous immunoglobulin (IVIG)

2 more in the full profile.

07

Biomarkers

Anti-idiotypic antibody titersB-cell receptor (BCR) repertoire diversitySerum autoantibody levels

Beyond the preview

Go deeper on Idiotype–anti-idiotype antibody network.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Idiotype–anti-idiotype antibody network.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call